文献速递癫痫认知障碍与痴呆

儿童疫苗相关热性惊厥后的发育结局

Developmental outcomes following vaccine-proximate febrile seizures in children.
PubMed 文献 · Neurology · 2020-07-01

这项前瞻性多中心队列研究比较了疫苗相关热性惊厥(VP-FS)、非疫苗相关热性惊厥(NVP-FS)及无惊厥对照儿童的发育和行为结局。结果显示三组在Bayley-III认知评分及其他测量上均无显著差异,VP-FS未增加发育或行为问题的风险。

要点

  • VP-FS儿童与NVP-FS及对照相比,认知功能无显著差异。
  • VP-FS未增加边缘/显著损害或临床范围行为问题的风险。
  • 家长和提供者可因VP-FS对儿童发育无不良影响而放心。

核心结论

  • VP-FS与NVP-FS或对照相比,未增加幼儿发育或行为问题的风险。

研究设计与样本

  • 前瞻性多中心队列研究,2013年5月至2016年4月从4家澳大利亚儿科医院招募30月龄前首次热性惊厥儿童,分为VP-FS和NVP-FS,并招募无惊厥史的同龄对照。

主要发现

  • VP-FS组(n=62)、NVP-FS组(n=70)和对照组(n=90)的Bayley-III认知评分无显著差异(F 2,219=2.645,p=0.07)。
  • 所有其他测量指标在组间均无差异。
  • VP-FS组与NVP-FS组或对照组相比,边缘/显著损害或临床范围行为问题的风险未增加。

临床怎么用

  • 对于发生VP-FS的幼儿,可告知家长其发育和行为结局与无惊厥儿童及NVP-FS儿童无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the developmental and behavioral outcomes of children experiencing an initial vaccine-proximate (VP) febrile seizure (FS) to those having a non-VP-FS (NVP-FS) and controls who have not had a seizure. METHODS: In this prospective multicenter cohort study, children with their first FS before 30 months of age between May 2013 and April 2016 were recruited from 4 Australian pediatric hospitals and classified as having VP-FS or NVP-FS. Similar-aged children with no seizure history were recruited as controls. The Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) was administered to participants with FS 12 to 24 months after their initial FS and to controls 12 to 42 months of age at the time of assessment. The primary outcome was the Bayley-III cognitive score. Children's preacademic skills were assessed with the Woodcock-Johnson Tests of Achievement, Third Edition, and their behavior and executive functioning were obtained from parent questionnaires. RESULTS: There was no significant difference in cognitive function between children with VP-FS (n = 62), those with NVP-FS (n = 70), and controls (n = 90) (F 2,219 = 2.645, p = 0.07). There were no differences between the groups for all other measures and no increased risk of borderline/significant impairment or behavior in the clinical range in children with VP-FS compared to those with NVP-FS or controls. CONCLUSION: VP-FS was not associated with an increased risk of developmental or behavioral problems in young children compared to children with NVP-FS or controls. Parents and providers should be reassured by the absence of adverse effects of VP-FS on the development of children.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Deng L, Wood N, Macartney K, et al. Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology. 2020. PMID: 32611632. doi:10.1212/WNL.0000000000009876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。